Raymond H Mak MD
Thoracic Cancer
Associate Professor of Radiation Oncology, Brigham and Women's Hospital / Dana-Farber Cancer Institute / Harvard Medical School
Join to View Full Profile
75 Francis StAsb1l2 Radiation Oncology Brigham Womens HospitalBoston, MA 02115
Phone+1 617-732-5500
Dr. Mak is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- I am an Associate Professor of Radiation Oncology at Harvard Medical School and Director of Clinical Innovation in the Department of Radiation Oncology at Brigham and Women’s Hospital/Dana-Farber Cancer Institute.
My clinical focus includes the treatment of thoracic malignancies, stereotactic body radiation therapy, and novel image-guided radiation therapy techniques. I led the implementation of the MR-guided radiation therapy program at BWH/DFCI in 2019.
My research interests focus on developing genomic and imaging biomarkers to predict radiation therapy response and toxicity for lung cancer patients and applying artificial intelligence techniques to automate radiation therapy planning and improve cancer care.
Education & Training
Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Radiation Oncology, 2007 - 2011- Mass General Brigham/Brigham and Women's HospitalResidency, Internal Medicine, 2006 - 2007
Harvard Medical SchoolClass of 2006
Certifications & Licensure
MA State Medical License 2008 - 2027
ME State Medical License 2020 - 2027
NH State Medical License 2023 - 2027
CT State Medical License 2022 - 2026
FL State Medical License 2022 - 2026
RI State Medical License 2021 - 2026
NY State Medical License 2021 - 2023
American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Clinical Trials
- Feasibility Study of Enhanced MRI for Early Stage Non Small Cell Lung Cancer (NSCLC) Start of enrollment: 2012 Nov 01
- Jump: MR Simulation For Radiation Therapy Master Protocol Start of enrollment: 2020 Oct 14
Roles: Contact, Principal Investigator
- CONFIRM: Magnetic Resonance Guided Radiation Therapy Start of enrollment: 2021 May 01
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- Cardiac substructure radiotherapy dose and changes in physical activity and quality of life after chemoradiotherapy for NSCLC: a secondary analysis of the CLARITY pros...Nikhil Yegya-Raman, Kyunga Ko, Ivy S Han, Joshua D Mitchell, Wei Zou
Clinical and Translational Radiation Oncology. 2026-01-01 - Associations Between G8 Geriatric Screening Score, Charlson Comorbidity Index, AI-Based Age Phenotype, and Overall Survival in Older Adults With Stage I-II Non-Small C...Leah L Thompson, Priya M Amin, Sanjana Shah, Sarah M Lipson, Jenny Yoon
International Journal of Radiation Oncology, Biology, Physics. 2025-12-01 - FaceAge as a biomarker for prognosis and treatment stratification in large-scale oncology cohort.Grace Lee, Fridolin Haugg, Dennis Bontempi, John He, Osbert Zalay
Journal of the National Cancer Institute. 2025-11-19
Journal Articles
- Association of Left Anterior Descending Coronary Artery Radiation Dose with Major Adverse Cardiac Events and Mortality in Patients with Non–Small Cell Lung CancerKatelyn M Atkins, David E Kozono, Elizabeth H Baldini, Raymond H Mak, JAMA Oncology
Press Mentions
Meet Seven Mass General Brigham Researchers Working to Develop New Therapies and Treatments for CancerSeptember 24th, 2025- What if a Selfie Could Predict Your Life Expectancy?May 22nd, 2025
- What Is FaceAge, the AI Tool That Can Tell How Healthy You Are from a Selfie?May 17th, 2025
- Join now to see all
Professional Memberships
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
